3-iodobenzylguanidine has been researched along with Atrial Fibrillation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, H; Iguchi, N; Isobe, M | 1 |
| Marcassa, C | 1 |
| Teresińska, A | 1 |
| Agostini, D; Baavour, R; Breault, C; Ernst, S; Gregg, S; Roth, N; Stirrup, J; Underwood, SR | 1 |
| Elesin, DA; Losik, DV; Mikheenko, IL; Minin, SM; Nikitin, NA; Pokushalov, EA; Romanov, AB; Shabanov, VV; Stenin, IG | 1 |
| Akutsu, Y; Asano, T; Gokan, T; Kaneko, K; Kobayashi, Y; Kodama, Y; Li, HL; Namiki, A; Shinozuka, A; Suyama, J; Tanno, K | 1 |
| Clements, IP; Hodge, DO; Jacobson, AF; Wiseman, GA | 1 |
| Breault, C; Minin, S; Pokushalov, E; Romanov, A | 1 |
| Ben-Haim, S; Lemery, R; Ruddy, TD; Wells, G | 1 |
| Akutsu, Y; Asano, T; Gokan, T; Hamazaki, Y; Kaneko, K; Kawamura, M; Kobayashi, Y; Kodama, Y; Li, HL; Shinozuka, A; Suyama, J; Tanno, K | 1 |
| Akutsu, Y; Gokan, T; Hamazaki, Y; Kaneko, K; Kobayashi, Y; Kodama, Y; Li, HL; Shinozuka, A; Suyama, J; Tanno, K | 1 |
| Crawford, MH | 1 |
| Aonuma, K; Arimoto, T; Igarashi, M; Koyama, T; Kuga, K; Kuroki, K; Machino, T; Sato, A; Sekiguchi, Y; Tada, H; Yamasaki, H | 1 |
| Arora, R | 1 |
| Duque, KS; Ovadia, M | 1 |
| Aida, J; Hirokawa, K; Ito, Y; Ohkawa, S; Okada, Y; Yasuhara, M | 1 |
| Bandou, K; Fukuda, N; Shinohara, H; Soeki, T; Sui, O; Takeichi, N; Tamura, Y; Tanaka, H; Yui, Y | 1 |
1 review(s) available for 3-iodobenzylguanidine and Atrial Fibrillation
| Article | Year |
|---|---|
The potential utility of (123)I-mIBG in atrial fibrillation and in the electrophysiology laboratory.
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Catheter Ablation; Cost-Benefit Analysis; Disease Progression; Female; Humans; Male; Patient Selection; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome; United States | 2012 |
1 trial(s) available for 3-iodobenzylguanidine and Atrial Fibrillation
| Article | Year |
|---|---|
Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hypertension; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 1998 |
15 other study(ies) available for 3-iodobenzylguanidine and Atrial Fibrillation
| Article | Year |
|---|---|
Detection of therapeutic targets for recurrent atrial fibrillation using 123I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Heart; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
MIBG and imaging of cardiac adrenergic system: From heart failure to ventricular arrhythmias and atrial fibrillation, through cardiac asynchrony. What else?
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Atrial Fibrillation; Heart; Heart Failure; Humans | 2022 |
I-123-MIBG cardiac innervation imaging in patients with atrial fibrillation.
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Heart; Heart Atria; Humans; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2020 |
Hybrid solid-state SPECT/CT left atrial innervation imaging for identification of left atrial ganglionated plexi: Technique and validation in patients with atrial fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Fibrillation; Female; Heart; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Observer Variation; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
[Visualisation and Radiofrequency Ablation of Sympathetic Innervation Loci in the Left Atrium in Patients with Paroxysmal Atrial Fibrillation].
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Heart Atria; Humans; Radiofrequency Ablation | 2019 |
Usefulness of severe cardiac sympathetic dysfunction to predict the occurrence of rapid atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Atrial Fibrillation; Case-Control Studies; Electrophysiologic Techniques, Cardiac; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 2013 |
Outcome prediction in heart failure with atrial fibrillation: relative role of left ventricular ejection fraction and neurohormonal measures.
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hormones; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Proportional Hazards Models; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2013 |
Visualization and ablation of the autonomic nervous system corresponding to ganglionated plexi guided by D-SPECT
Topics: 3-Iodobenzylguanidine; Action Potentials; Atrial Fibrillation; Catheter Ablation; Female; Ganglia, Autonomic; Heart; Heart Rate; Humans; Iodine Radioisotopes; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2017 |
I-123-Metaiodobenzylguanidine imaging in patients with atrial fibrillation undergoing cardiac mapping and ablation of autonomic ganglia.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Fibrillation; Body Surface Potential Mapping; Catheter Ablation; Female; Ganglia, Autonomic; Heart Atria; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2017 |
Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Fibrillation; C-Reactive Protein; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Iodine Radioisotopes; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk; Stroke; Sympathetic Nervous System | 2010 |
Iodine-123 mIBG Imaging for Predicting the Development of Atrial Fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Fibrillation; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2011 |
Does cardiac sympathetic innervation imaging fulfill an unmet need for managing atrial fibrillation?
Topics: 3-Iodobenzylguanidine; Atrial Fibrillation; Heart; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Stroke Volume; Sympathetic Nervous System | 2011 |
High washout rate of iodine-123-metaiodobenzylguanidine imaging predicts the outcome of catheter ablation of atrial fibrillation.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Fibrillation; Autonomic Denervation; Catheter Ablation; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2011 |
Sympathetic imaging with 123-I-MIBG--a new way to predict recurrences after AF ablation.
Topics: 3-Iodobenzylguanidine; Animals; Atrial Fibrillation; Autonomic Nervous System; Catheter Ablation; Female; Heart; Humans; Male; Pulmonary Veins; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Ganglia, Autonomic; Heart; Humans; Lewy Bodies; Lewy Body Disease; Male; Parkinson Disease; Radionuclide Imaging; Sinoatrial Node | 2004 |